Search Within

GDMT, Medicine

Formats
  1. Journal Article (929)
  2. Meeting Abstract (829)
  3. Review (49)
  4. Book Section (38)
  5. Editorial (29)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1901)
  2. Department of Medicine (1890)
  3. Solid Tumor Oncology Division (1890)
  4. Gynecologic Medicine Service (1850)
  5. Surgery (582)
  6. GDMT, Surgery (465)

More Groups

People
  1. Carol Aghajanian (613)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (279)
  4. Roisin O'Cearbhaill (272)
  5. Vicky Makker (267)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (64)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Journal of Clinical Oncology (418)
  2. Gynecologic Oncology (416)
  3. International Journal of Gynecological Cancer (152)
  4. Annals of Oncology (106)
  5. Clinical Cancer Research (64)
  6. Cancer (37)

More Publications

Publishers
  1. Elsevier Inc. (496)
  2. American Society of Clinical Oncology (450)
  3. Lippincott Williams & Wilkins (177)
  4. American Association for Cancer Research (139)
  5. Oxford University Press (128)
  6. Nature Publishing Group (73)

More Publishers

Results (1901)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy
    Meeting Abstract

    Klepin, H. D.; Sun, C. L.; Smith, D. D.; Elias, R.; Trevino, K. M.; Bryant, A. L.; Nelson, C. J.; Tew, W. P.; Mohile, S. G.; Owusu, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study
    Meeting Abstract

    Lacouture, M. E.; Konner, J. A.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • ADXS11-001 immunotherapy in squamous or non-squamous persistent/recurrent metastatic cervical cancer: Results from stage I of the phase II GOG/NRG0265 study
    Meeting Abstract

    Huh, W. K.; Dizon, D. S.; Powell, M. A.; Leath, C. A.; Landrum, L. M.; Tanner, E.; Higgins, R.; Ueda, S. M.; McHale, M. T.; Monk, B. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Toxicity associated with ipilimumab and nivolumab (Ipi plus Nivo) combination therapy in melanoma patients (pts) treated at a single-institution under an expanded-access program (EAP)
    Meeting Abstract

    Friedman, C. F.; Navid-Azarbaijani, P.; Shoushtari, A. N.; Campbell, S. C.; Callahan, M. K.; Momtaz, P.; Prempeh-Keteku, N. A.; Postow, M. A.; Shames, Y.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80+)
    Meeting Abstract

    Friedman, C. F.; Horvat, T. Z.; Minehart, J.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS)
    Meeting Abstract

    Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Elias, A. D.; Pierson, R. F.; Knoblauch, R. E.; Park, Y. C.; Wang, G. C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Bevacizumab after bevacizumab in platinum-sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213
    Meeting Abstract

    Coleman, R. L.; Brady, M. F.; Herzog, T. J.; Armstrong, D. K.; Sabbatini, P.; Walker, J. L.; Kim, B.; Fujiwara, K.; Tewari, K. S.; O'Malley, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • PHASE II evaluation of dalantercept for persistent or recurrent epithelial ovarian and related cancers: An NRG oncology study
    Meeting Abstract

    Burger, R. A.; Deng, W.; Makker, V.; Lankes, H. A.; Aghajanian, C.; Gray, H. J.; Wade, J. L.; Waggoner, S. E.; Levine, D. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical characterization of DNA mismatch repair deficiency (MMR-D) in endometrial cancer (EC)
    Meeting Abstract

    Cadoo, K. A.; Tran, C.; DeLair, D.; Arnold, A. G.; Ashraf, A.; Jewell, E. L.; Kauff, N. D.; Long, K.; Mueller, J. J.; Robson, M. E.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save